K-Ras mutation status as a predictive biomarker in metastatic colorectal cancer
Why do we need to understand the molecular basis of depression?
New potential multiplex biomarker test for detecting prostate cancer
Interferon-γ: a possible predictive biomarker for the clearance of human papillomavirus in women
Functional genomics may have identified blood biomarkers for mood disorders
Status of KRAS is required for Vectibix™ efficacy in cancer
Complexities in drug trials: enrichment, biomarkers and surrogates
Neuronal and vascular biomarkers in syringomyelia: investigations using longitudinal MRI
IL-6 as a biomarker of ischemic cerebrovascular disease
Clinical utility of circulating tumor cells: a role for monitoring response to therapy and drug development
Opportunities posed by novel patient selection biomarker approaches in oncology drug development: going beyond the cytotoxics
Biomarkers in radiation oncology
Urine cytology and urine-based markers for bladder urothelial carcinoma detection and monitoring: developments and future prospects
Biomarkers in oncology research and treatment: early detection research network: a collaborative approach
Acknowledgements